CD5+ regulatory B cells are present in murine bladder cancer, while in prostate cancer, CD138+IgA+PD-L1+ B cells promote tumor progression by secreting the immunosuppressive cytokine IL-10 [27,55]. Here, CD79A is linked to prostate carcinoma.